Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.

Moens B, Pannecouque C, López G, Talledo M, Gotuzzo E, Khouri R, Bittencourt A, Farré L, Galvão-Castro B, Vandamme AM, Van Weyenbergh J.

Virol J. 2012 Aug 23;9:171. doi: 10.1186/1743-422X-9-171.

2.

Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.

Kinpara S, Kijiyama M, Takamori A, Hasegawa A, Sasada A, Masuda T, Tanaka Y, Utsunomiya A, Kannagi M.

Retrovirology. 2013 May 20;10:52. doi: 10.1186/1742-4690-10-52.

3.

Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Gudo ES, Bhatt NB, Bila DR, Abreu CM, Tanuri A, Savino W, Silva-Barbosa SD, Jani IV.

BMC Infect Dis. 2009 Dec 22;9:211. doi: 10.1186/1471-2334-9-211.

4.

Retroviral interference on STAT activation in individuals coinfected with human T cell leukemia virus type 2 and HIV-1.

Bovolenta C, Pilotti E, Mauri M, Panzeri B, Sassi M, Dall'Aglio P, Bertazzoni U, Poli G, Casoli C.

J Immunol. 2002 Oct 15;169(8):4443-9.

5.

T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

Casseb J, Posada-Vergara MP, Montanheiro P, Fukumori LM, Olah I, Smid J, Duarte AJ, Penalva de Oliveira AC.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):231-3.

6.
7.
8.

Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.

Kinpara S, Hasegawa A, Utsunomiya A, Nishitsuji H, Furukawa H, Masuda T, Kannagi M.

J Virol. 2009 May;83(10):5101-8. doi: 10.1128/JVI.02564-08. Epub 2009 Mar 4.

9.

Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.

Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR.

Blood. 2000 Feb 15;95(4):1386-92.

10.

Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro.

D'Onofrio C, Franzese O, Puglianiello A, Peci E, Lanzilli G, Bonmassar E.

Int J Immunopharmacol. 1992 Aug;14(6):1069-79.

PMID:
1428362
12.

Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Fukushima N, Nishiura Y, Nakamura T, Kohno S, Eguchi K.

Intern Med. 2007;46(7):347-51. Epub 2007 Apr 2.

13.

Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.

Moens B, Decanine D, Menezes SM, Khouri R, Silva-Santos G, Lopez G, Alvarez C, Talledo M, Gotuzzo E, de Almeida Kruschewsky R, Galvão-Castro B, Vandamme AM, Van Weyenbergh J.

PLoS Negl Trop Dis. 2012;6(7):e1729. doi: 10.1371/journal.pntd.0001729. Epub 2012 Jul 24.

14.

Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.

Takatsuka N, Hasegawa A, Takamori A, Shimizu Y, Kato H, Ohashi T, Amagasa T, Masuda T, Kannagi M.

Int Immunol. 2009 Sep;21(9):1089-100. doi: 10.1093/intimm/dxp074. Epub 2009 Aug 4.

PMID:
19654198
15.

IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.

Brito-Melo GE, Peruhype-Magalhães V, Teixeira-Carvalho A, Barbosa-Stancioli EF, Carneiro-Proietti AB, Catalan-Soares B, Ribas JG; Grupo Interdisciplinar de Pesquisas sobre HTLV (GIPH), Martins-Filho OA.

Clin Exp Immunol. 2007 Jan;147(1):35-44.

17.

Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.

Bhatt NB, Gudo ES, Semá C, Bila D, Di Mattei P, Augusto O, Garsia R, Jani IV.

Int J STD AIDS. 2009 Dec;20(12):863-8. doi: 10.1258/ijsa.2008.008401.

PMID:
19948902
18.

IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.

Best I, López G, Verdonck K, González E, Tipismana M, Gotuzzo E, Vanham G, Clark D.

Immunology. 2009 Sep;128(1 Suppl):e777-86. doi: 10.1111/j.1365-2567.2009.03082.x. Epub 2009 Feb 17.

19.

Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.

Gordon SN, Weissman AR, Cecchinato V, Fenizia C, Ma ZM, Lee TH, Zaffiri L, Andresen V, Parks RW, Jones KS, Heraud JM, Ferrari MG, Chung HK, Venzon D, Mahieux R, Murphy EL, Jacobson S, Miller CJ, Ruscetti FW, Franchini G.

J Virol. 2010 Mar;84(6):3043-58. doi: 10.1128/JVI.01655-09. Epub 2010 Jan 13.

20.

Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

Supplemental Content

Support Center